{"id":669,"date":"2021-01-26T16:28:57","date_gmt":"2021-01-26T15:28:57","guid":{"rendered":"https:\/\/www.icta.fr\/?page_id=669"},"modified":"2024-06-25T10:58:13","modified_gmt":"2024-06-25T08:58:13","slug":"publications","status":"publish","type":"page","link":"https:\/\/www.icta.fr\/fr\/publications\/","title":{"rendered":"Publications"},"content":{"rendered":"\n

<\/p>\n\n\n\n

<\/div>
\n


Au sein du d\u00e9partement affaires m\u00e9dicales et scientifiques, notre \u00e9quipe de r\u00e9dacteurs m\u00e9dicaux travaille en \u00e9troite collaboration avec l’ensemble de nos d\u00e9partements op\u00e9rationnels, l’assurance qualit\u00e9 et la biom\u00e9trie.<\/h2>\n\n\n\n

Ils assurent la r\u00e9daction de tous les documents li\u00e9s \u00e0 l’\u00e9tude, et publications scientifiques, en particulier :<\/p>\n\n\n\n

\u25beles rapports d’\u00e9tude cliniques<\/p>\n\n\n\n

\u25beles articles selon les standards des publications s\u00e9lectionn\u00e9es<\/p>\n\n\n\n

\u25beles posters (avec insertion de graphiques, de diagrammes et d’illustrations)<\/p>\n\n\n\n

\u25beles abstracts<\/p>\n\n\n\n

D\u00e9couvrez comment nos r\u00e9dacteurs m\u00e9dicaux, en tant que r\u00e9dacteurs et\/ou auteurs, transforment vos r\u00e9sultats cliniques en mots et les valorisent en consultant une s\u00e9lection de nos articles et posters sur les 5 derni\u00e8res ann\u00e9es.<\/p>\n<\/div><\/section>\n\n\n\n

<\/div>
\n
\n \t\t\t\t\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\n
\n
\n
\n
\n

Des m\u00e9decins non sp\u00e9cialistes traitent avec succ\u00e8s l’h\u00e9patite C gr\u00e2ce \u00e0 un parcours de soins simplifi\u00e9 en France<\/h3><\/div>\n<\/div>\n\n\n\n
\n
\n
\n Article<\/div>\n\n\n\n
\n Afin d’\u00e9radiquer l’infection par le virus de l’h\u00e9patite C (VHC) en France, le droit de prescrire le sofosbuvir\/velpatasvir (SOF\/VEL) a \u00e9t\u00e9 \u00e9tendu aux m\u00e9decins non sp\u00e9cialistes et un parcours de soins simplifi\u00e9 a \u00e9t\u00e9 mis en place pour les patients non gravement atteints. <\/div>\n\n\n\n

<\/p>\n<\/div>\n\n\n\n

<\/div>\n<\/div>\n<\/div>\n<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\n
\n
\n
\n
\n

Acc\u00e9l\u00e9rer les recrutements dans les essais cliniques : un d\u00e9fi strat\u00e9gique<\/h3><\/div>\n<\/div>\n\n\n\n
\n
\n
\n Article<\/div>\n\n\n\n
\n Le recrutement des patients reste un d\u00e9fi majeur dans la recherche clinique… et n\u00e9cessite encore des am\u00e9liorations structurelles en France.\r\nDans la pratique, le recrutement est souvent le principal facteur d\u00e9terminant les d\u00e9lais, la faisabilit\u00e9 et la r\u00e9ussite globale d’un essai. Pourtant, de nombreuses \u00e9tudes continuent de subir des retards.<\/div>\n\n\n\n

<\/p>\n<\/div>\n\n\n\n

<\/div>\n<\/div>\n<\/div>\n<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\n
\n
\n
\n
\n

Pain Relief and Protection of Corns, Calluses and Bunions Using COMPEED\u00ae Foot Care Hydrocolloid Plasters: A Prospective Non-Interventional Study in Primary Care\/Community Pharmacies<\/h3><\/div>\n<\/div>\n\n\n\n
\n
\n
\n Article<\/div>\n\n\n\n
\n Pathologic hyperkeratosis due to skin thickness increase includes corn, callous, and bunion. These conditions can cause important pain and discomfort. Treatment relies on eliminating the cause of friction and\/or rubbing. Moreover, hydrocolloid occlusive dressings rehydrate hard skin, leading to maceration, facilitating removal of dead skin. <\/div>\n\n\n\n

<\/p>\n<\/div>\n\n\n\n

<\/div>\n<\/div>\n<\/div>\n<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\n
\n
\n
\n
\n

Comparaison indirecte \u00e0 l\u2019aide de donn\u00e9es issues de la litt\u00e9rature : Application \u00e0 une \u00e9tude visant \u00e0 valider la non-inf\u00e9riorit\u00e9 d\u2019un nouveau dispositif m\u00e9dical \u00e0 un dispositif standard dans la s\u00e9cheresse oculaire<\/h3><\/div>\n<\/div>\n\n\n\n
\n
\n
\n Poster<\/div>\n\n\n\n
\n Pr\u00e9sent\u00e9 lors du colloque de l’AFCROS Donn\u00e9es de Sant\u00e9 en Vie R\u00e9elle<\/div>\n\n\n\n

<\/p>\n<\/div>\n\n\n\n

<\/div>\n<\/div>\n<\/div>\n<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\n
\n
\n
\n
\n

Identifying effect of a treatment from observational data in absence of contemporaneous control \u2013 Example of the TOSCA study, comparing the efficacy of cemiplimab vs. Historical Systemic Treatment in Cutaneous Squamous Cell Carcinoma in France<\/h3><\/div>\n<\/div>\n\n\n\n
\n
\n
\n Poster<\/div>\n\n\n\n
\n Pr\u00e9sent\u00e9 lors du congr\u00e8s ISPOR Europe 2023 qui s’est tenu les 12-15 Novembre 2023 \u00e0 Copenhague<\/div>\n\n\n\n

<\/p>\n<\/div>\n\n\n\n

<\/div>\n<\/div>\n<\/div>\n<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\n
\n
\n
\n
\n

Final results on effectiveness and safety of Ibrutinib in patients with chronic lymphocytic leukemia from the non-interventional FIRE study<\/h3><\/div>\n<\/div>\n\n\n\n
\n
\n
\n Publication<\/div>\n\n\n\n
\n Publi\u00e9 dans Springer Link – Annals of Hematology – March 2024<\/div>\n\n\n\n

<\/p>\n<\/div>\n\n\n\n

<\/div>\n<\/div>\n<\/div>\n<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\n
\n
\n
\n
\n

Prevention of foot blisters using COMPEED\u00aehydrocolloid plasters: a randomized, open-labelled comparative superiority clinical investigation versus regular plasters<\/h3><\/div>\n<\/div>\n\n\n\n
\n
\n
\n Publication<\/div>\n\n\n\n
\n Publi\u00e9 dans Clinical Research and Trials \r\nVolume 9: 1-7, 2023 doi: 10.15761\/CRT.1000372<\/div>\n\n\n\n

<\/p>\n<\/div>\n\n\n\n

<\/div>\n<\/div>\n<\/div>\n<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\n
\n
\n
\n
\n

A Randomized, Double-Blind, and Sham-Controlled Trial of an Innovative Brain-Gut Photobiomodulation Therapy: Safety and Patient Compliance<\/h3><\/div>\n<\/div>\n\n\n\n
\n
\n
\n Article<\/div>\n\n\n\n
\n Publi\u00e9 dans le “Journal of Alzheimer\u2019s Disease”<\/div>\n\n\n\n

<\/p>\n<\/div>\n\n\n\n

<\/div>\n<\/div>\n<\/div>\n<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\n
\n
\n
\n
\n

Ponatinib Long-Term Follow-up of Efficacy and Safety in CP-CML Patients in Real World Settings in France: the POST-PACE Study<\/h3><\/div>\n<\/div>\n\n\n\n
\n
\n
\n Article<\/div>\n\n\n\n
\n Publi\u00e9 dans la revue “Leukemia research”<\/div>\n\n\n\n

<\/p>\n<\/div>\n\n\n\n

<\/div>\n<\/div>\n<\/div>\n<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\n
\n
\n
\n
\n

Scientific and methodological consistency throughout a clinical study: How to succeed?<\/h3><\/div>\n<\/div>\n\n\n\n
\n
\n
\n Poster<\/div>\n\n\n\n
\n Pr\u00e9sent\u00e9 lors du congr\u00e8s PHUSE 2020<\/div>\n\n\n\n

<\/p>\n<\/div>\n\n\n\n

<\/div>\n<\/div>\n<\/div>\n<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\n
\n
\n
\n
\n

Am\u00e9lioration de la qualit\u00e9 de vie et de la continence des patients atteints de RCH distale, trait\u00e9s par M\u00e9salazine. \u00c9tude QUARTZ<\/h3><\/div>\n<\/div>\n\n\n\n
\n
\n
\n Poster<\/div>\n\n\n\n
\n Pr\u00e9sent\u00e9 lors des JFHOD (Journ\u00e9es Fran\u00e7aises d\u2019H\u00e9pato-Oncologie Digestive)<\/div>\n\n\n\n

<\/p>\n<\/div>\n\n\n\n

<\/div>\n<\/div>\n<\/div>\n<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\n
\n
\n
\n
\n

Exploitation des Donn\u00e9es de Vie R\u00e9elle Issues d\u2019un Registre en Oncologie : Comment Identifier les Lignes de Chimioth\u00e9rapie d\u2019une Cohorte de Patientes Atteintes d\u2019un Cancer Ovarien<\/h3><\/div>\n<\/div>\n\n\n\n
\n
\n
\n Poster<\/div>\n\n\n\n
\n Pr\u00e9sent\u00e9 lors du 12\u00e8me Colloque Donn\u00e9es de sant\u00e9 en vie r\u00e9elle organis\u00e9 par l’AFCROs<\/div>\n\n\n\n

<\/p>\n<\/div>\n\n\n\n

<\/div>\n<\/div>\n<\/div>\n<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\n
\n
\n
\n
\n

Evolution of Hepatitis C Virus Treatment During the Era of Sofosbuvir-Based Therapies: A Real-World Experience in France.<\/h3><\/div>\n<\/div>\n\n\n\n
\n
\n
\n Article<\/div>\n\n\n\n
\n Publi\u00e9 dans la revue “Digestive Diseases and Sciences”<\/div>\n\n\n\n

<\/p>\n<\/div>\n\n\n\n

<\/div>\n<\/div>\n<\/div>\n<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\n
\n
\n
\n
\n

Improvement of Quality of life and continence in patients with distal ulcerative colitis treated by mesalazine. The QUARTZ study<\/h3><\/div>\n<\/div>\n\n\n\n
\n
\n
\n Poster<\/div>\n\n\n\n
\n Pr\u00e9sent\u00e9 lors du congr\u00e8s ECCO (European Crohn\u2019s an Colitis Organisation)<\/div>\n\n\n\n

<\/p>\n<\/div>\n\n\n\n

<\/div>\n<\/div>\n<\/div>\n<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\n
\n
\n
\n
\n

Letermovir for Secondary Prophylaxis of Cytomegalovirus Infection and Disease after Allogeneic Hematopoietic Cell Transplantation: Results from the French Compassionate Program<\/h3><\/div>\n<\/div>\n\n\n\n
\n
\n
\n Article<\/div>\n\n\n\n
\n Publi\u00e9 dans la revue “Biology of Blood and Marrow Transplantation”<\/div>\n\n\n\n

<\/p>\n<\/div>\n\n\n\n

<\/div>\n<\/div>\n<\/div>\n<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\n
\n
\n
\n
\n

Ponatinib Long-Term Follow-up of Efficacy and Safety in CP-CML Patients in Real World Settings in France: The Post-PACE Study<\/h3><\/div>\n<\/div>\n\n\n\n
\n
\n
\n Poster<\/div>\n\n\n\n
\n Pr\u00e9sent\u00e9 lors du congr\u00e8s “ESH-iCML (Annual John Goldman Conference on Chronic Myeloid Leukemia: Biology and Therapy)”<\/div>\n\n\n\n

<\/p>\n<\/div>\n\n\n\n

<\/div>\n<\/div>\n<\/div>\n<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\n
\n
\n
\n
\n

Phase 2 study results of Murlentamab, a monoclonal antibody targeting the anti-mullerian hormone receptor II (AMHRII), acting through tumor associated macrophage (TAM) engagement in advanced\/metastatic colorectal cancer<\/h3><\/div>\n<\/div>\n\n\n\n
\n
\n
\n Poster<\/div>\n\n\n\n
\n Pr\u00e9sent\u00e9 lors du congr\u00e8s ESMO WCGIC (World Congress on Gastrointestinal Cancer) \u2013 2019<\/div>\n\n\n\n

<\/p>\n<\/div>\n\n\n\n

<\/div>\n<\/div>\n<\/div>\n<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\n
\n
\n
\n
\n

\u00c9tude observationnelle, prospective d\u00e9crivant les caract\u00e9ristiques et la prise en charge de femmes atteintes d\u2019une ost\u00e9oporose post-m\u00e9nopausique trait\u00e9es par Prolia\u00ae et son utilisation en pratique clinique courante en France (\u00e9tude PILOTE)<\/h3><\/div>\n<\/div>\n\n\n\n
\n
\n
\n Article<\/div>\n\n\n\n
\n Publi\u00e9 dans la Revue d\u2019\u00e9pid\u00e9miologie et de sant\u00e9 publique<\/div>\n\n\n\n

<\/p>\n<\/div>\n\n\n\n

<\/div>\n<\/div>\n<\/div>\n<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\n
\n
\n
\n
\n

First-in-human first-in-class phase I trial of Murlentamab, a an Anti-M\u00fcllerian-Hormone-Receptor II (AMHRII) monoclonal antibody acting through Tumor Associated Macrophage (TAM) engagement, as single agent and in combination with Carboplatin (C) and Paclitaxel (P) in AMHRII-expressing advanced\/metastatic gynecological cancer patients (pts)<\/h3><\/div>\n<\/div>\n\n\n\n
\n
\n
\n Poster<\/div>\n\n\n\n
\n Pr\u00e9sent\u00e9 lors de l’ASCO (American Society of Clinical Oncology) 2019<\/div>\n\n\n\n

<\/p>\n<\/div>\n\n\n\n

<\/div>\n<\/div>\n<\/div>\n<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\n
\n
\n
\n
\n

No effect of alcohol consumption or dependence on treatment outcome in chronic hepatitis C patients treated with Elbasvir\/Grazoprevir in real-world setting<\/h3><\/div>\n<\/div>\n\n\n\n
\n
\n
\n Poster<\/div>\n\n\n\n
\n Pr\u00e9sent\u00e9 lors du congr\u00e8s EASL (European Association for the Study of the Liver)<\/div>\n\n\n\n

<\/p>\n<\/div>\n\n\n\n

<\/div>\n<\/div>\n<\/div>\n<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\n
\n
\n
\n
\n

Letermovir for prophylaxis of Cytomegalovirus (CMV) infection or disease in allogeneic HCT recipients: experience of secondary prophylaxis in the French Compassionate program<\/h3><\/div>\n<\/div>\n\n\n\n
\n
\n
\n Poster<\/div>\n\n\n\n
\n Pr\u00e9sent\u00e9 lors du congr\u00e8s EBMT (European Society of Blood and Marrow Transplantation) 2019<\/div>\n\n\n\n

<\/p>\n<\/div>\n\n\n\n

<\/div>\n<\/div>\n<\/div>\n<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\n
\n
\n
\n
\n

Premiers r\u00e9sultats de l\u2019\u00e9tude multicentrique prospective observationnelle avec l\u2019association elbasvir\/grazopr\u00e9vir dans le traitement de l\u2019h\u00e9patite chronique C en France : observatoire ZEPHYR<\/h3><\/div>\n<\/div>\n\n\n\n
\n
\n
\n Poster<\/div>\n\n\n\n
\n Pr\u00e9sent\u00e9 lors des JFHOD (Journ\u00e9es Francophones d\u2019H\u00e9pato-gastroent\u00e9rologie et d\u2019Oncologie Digestive)<\/div>\n\n\n\n

<\/p>\n<\/div>\n\n\n\n

<\/div>\n<\/div>\n<\/div>\n<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\n
\n
\n
\n
\n

Filgrastim prophylaxis in elderly cancer patients in the real-life setting: a French multicenter observational study, the TULIP study<\/h3><\/div>\n<\/div>\n\n\n\n
\n
\n
\n Article<\/div>\n\n\n\n
\n Publi\u00e9 dans la revue “Support Care Cancer”<\/div>\n\n\n\n

<\/p>\n<\/div>\n\n\n\n

<\/div>\n<\/div>\n<\/div>\n<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\n
\n
\n
\n
\n

Gaucher Disease: Baseline Preliminary Data of the French Eliglustat Patient Reported Outcome Study (ELIPRO)<\/h3><\/div>\n<\/div>\n\n\n\n
\n
\n
\n Poster<\/div>\n\n\n\n
\n Pr\u00e9sent\u00e9 lors du WORLD Symposium<\/div>\n\n\n\n

<\/p>\n<\/div>\n\n\n\n

<\/div>\n<\/div>\n<\/div>\n<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\n
\n
\n
\n
\n

Micafungin prophylaxis in routine medical practice in adult and pediatric patients with hematological malignancy: a prospective, observational study in France.<\/h3><\/div>\n<\/div>\n\n\n\n
\n
\n
\n Article<\/div>\n\n\n\n
\n Publi\u00e9 dans la revue “Diagnostic Microbiology and Infectious Disease”<\/div>\n\n\n\n

<\/p>\n<\/div>\n\n\n\n

<\/div>\n<\/div>\n<\/div>\n<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\n
\n
\n
\n
\n

Technique d’inhalation des sujets asthmatiques utilisant Duoresp Spiromax en condition de vie r\u00e9elle.<\/h3><\/div>\n<\/div>\n\n\n\n
\n
\n
\n Poster<\/div>\n\n\n\n
\n Pr\u00e9sent\u00e9 lors du CPLF (Congr\u00e8s de Pneumologie de Langue Fran\u00e7aise) <\/div>\n\n\n\n

<\/p>\n<\/div>\n\n\n\n

<\/div>\n<\/div>\n<\/div>\n<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\n
\n
\n
\n
\n

Results and validation of an index to measure health state of patients with depression in automated healthcare databases.<\/h3><\/div>\n<\/div>\n\n\n\n
\n
\n
\n Article<\/div>\n\n\n\n
\n Publi\u00e9 dans “Journal of Market Access & Health Policy”<\/div>\n\n\n\n

<\/p>\n<\/div>\n\n\n\n

<\/div>\n<\/div>\n<\/div>\n<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\n
\n
\n
\n
\n

The challenge of unexplained splenomegalies: preliminary data of the French prospective multi-center SplenoMegalyStudy (SMS)<\/h3><\/div>\n<\/div>\n\n\n\n
\n
\n
\n Poster<\/div>\n\n\n\n
\n Pr\u00e9sent\u00e9 lors du congr\u00e8s ASH (American Society of Hematology) OUTCOMES RESEARCH-NON-MALIGNANT HEMATOLOGY: POSTER III| NOVEMBER 29, 2018<\/div>\n\n\n\n

<\/p>\n<\/div>\n\n\n\n

<\/div>\n<\/div>\n<\/div>\n<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\n
\n
\n
\n
\n

Etude multicentrique prospective observationnelle de l’association elbasvir\/grazopr\u00e9vir dans le traitement de l’h\u00e9patite chronique C en France : observatoire zephyr<\/h3><\/div>\n<\/div>\n\n\n\n
\n
\n
\n Poster<\/div>\n\n\n\n
\n Pr\u00e9sent\u00e9 lors de l’AFEF (Association Fran\u00e7aise pour l\u2019\u00c9tude du Foie) – R\u00e9sum\u00e9 n\u00b0P020<\/div>\n\n\n\n

<\/p>\n<\/div>\n\n\n\n

<\/div>\n<\/div>\n<\/div>\n<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\n
\n
\n
\n
\n

Tacrolimus Granules for Oral Suspension as Post-Transplant Immunosuppression in Routine Medical Practice in France: The OPTIMOD Study<\/h3><\/div>\n<\/div>\n\n\n\n
\n
\n
\n Article<\/div>\n\n\n\n
\n Publi\u00e9 dans la revue “Annals of Transplantation”<\/div>\n\n\n\n

<\/p>\n<\/div>\n\n\n\n

<\/div>\n<\/div>\n<\/div>\n<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\n
\n
\n
\n
\n

Systemic Antifungal Prophylaxis in Patients Hospitalized in Hematology Units in France: The AFHEM Cross-Sectional Observational Study.<\/h3><\/div>\n<\/div>\n\n\n\n
\n
\n
\n Article<\/div>\n\n\n\n
\n Publi\u00e9 dans la revue “Infectious Diseases and Therapy”<\/div>\n\n\n\n

<\/p>\n<\/div>\n\n\n\n

<\/div>\n<\/div>\n<\/div>\n<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\n
\n
\n
\n
\n

A First-In-Human study of monoclonal antibody GM102 in patients in patients with Anti Anti -M\u00fcllerian -Hormone -Receptor II (AMHRII) positive gynecological cancers<\/h3><\/div>\n<\/div>\n\n\n\n
\n
\n
\n Poster<\/div>\n\n\n\n
\n Pr\u00e9sent\u00e9 lors de l’ASCO (American Society of Clinical Oncology)<\/div>\n\n\n\n

<\/p>\n<\/div>\n\n\n\n

<\/div>\n<\/div>\n<\/div>\n<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\n
\n
\n
\n
\n

Prospective evaluation of the effect of deferasirox on hematologic response in transfusion-dependent patients with low-risk MDS and iron overload.<\/h3><\/div>\n<\/div>\n\n\n\n
\n
\n
\n Article<\/div>\n\n\n\n
\n Published in European Journal of Haematology<\/div>\n\n\n\n

<\/p>\n<\/div>\n\n\n\n

<\/div>\n<\/div>\n<\/div>\n<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\n
\n
\n
\n
\n

Apixaban in the prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation in France: Rationale and design of the PAROS cross-sectional study<\/h3><\/div>\n<\/div>\n\n\n\n
\n
\n
\n Article<\/div>\n\n\n\n
\n Published in Archives of Cardiovascular Diseases<\/div>\n\n\n\n

<\/p>\n<\/div>\n\n\n\n

<\/div>\n<\/div>\n<\/div>\n<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\n
\n
\n
\n
\n

An Auto-Adjustable Night Garment to Control Early Rebound Effect of Edema Volume After Intensive Phase of Decongestive Lymphedema Therapy<\/h3><\/div>\n<\/div>\n\n\n\n
\n
\n
\n Article<\/div>\n\n\n\n
\n Publi\u00e9 dans la revue “Lymphatic Research and Biology” <\/div>\n\n\n\n

<\/p>\n<\/div>\n\n\n\n

<\/div>\n<\/div>\n<\/div>\n<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\n
\n
\n
\n
\n

Creating an index to measure health state of depressed patients in automated healthcare databases: the methodology<\/h3><\/div>\n<\/div>\n\n\n\n
\n
\n
\n Article<\/div>\n\n\n\n
\n Publi\u00e9 dans le “Journal of Market Access & Health Policy 2017”<\/div>\n\n\n\n

<\/p>\n<\/div>\n\n\n\n

<\/div>\n<\/div>\n<\/div>\n<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\n
\n
\n
\n
\n

Poor sleep is highly associated with house dust mite allergic rhinitis in adults and children.<\/h3><\/div>\n<\/div>\n\n\n\n
\n
\n
\n Article<\/div>\n\n\n\n
\n Publi\u00e9 dans la revue “Allergy, Asthma & Clinical Immunology”<\/div>\n\n\n\n

<\/p>\n<\/div>\n\n\n\n

<\/div>\n<\/div>\n<\/div>\n<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\n
\n
\n
\n
\n

Interest of an auto-adjustable nighttime compression sleeve (MOBIDERM\u00ae Autofit) in maintenance phase of upper limb lymphedema: the MARILYN pilot RCT.<\/h3><\/div>\n<\/div>\n\n\n\n
\n
\n
\n Article<\/div>\n\n\n\n
\n Publi\u00e9 dans la revue “Supportive Care in Cancer”<\/div>\n\n\n\n

<\/p>\n<\/div>\n\n\n\n

<\/div>\n<\/div>\n<\/div>\n<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t <\/div>\n\n <\/div>\n <\/div><\/section>\n\n\n\n
<\/div>
\n
\n
\n
\"RGPD<\/figure>\n<\/div><\/div>\n\n\n\n
\n
\"21<\/figure>\n<\/div><\/div>\n\n\n\n
\n
\"ecovadis<\/figure>\n<\/div><\/div>\n\n\n\n
\n
\"cr\u00e9dit<\/figure>\n<\/div><\/div>\n\n\n\n
\n
\"bureau<\/figure>\n<\/div><\/div>\n\n\n\n
\n
\"bureau<\/figure>\n<\/div><\/div>\n\n\n\n
\n
\"\"<\/figure>\n<\/div><\/div>\n<\/div>\n<\/div><\/section>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":1,"featured_media":1378,"parent":0,"menu_order":44,"comment_status":"closed","ping_status":"closed","template":"typegrey.php","meta":{"_acf_changed":false,"_editorskit_title_hidden":false,"_editorskit_reading_time":1,"_editorskit_is_block_options_detached":false,"_editorskit_block_options_position":"{}","inline_featured_image":false,"_uag_custom_page_level_css":"","kk_blocks_editor_width":"","_kiokenblocks_attr":"","_kiokenblocks_dimensions":"","footnotes":""},"class_list":["post-669","page","type-page","status-publish","has-post-thumbnail","hentry"],"acf":[],"uagb_featured_image_src":{"full":["https:\/\/www.icta.fr\/wp-content\/uploads\/Bandeau_Titre_Publications-1.jpg",1920,162,false],"thumbnail":["https:\/\/www.icta.fr\/wp-content\/uploads\/Bandeau_Titre_Publications-1-128x88.jpg",128,88,true],"medium":["https:\/\/www.icta.fr\/wp-content\/uploads\/Bandeau_Titre_Publications-1-300x25.jpg",300,25,true],"medium_large":["https:\/\/www.icta.fr\/wp-content\/uploads\/Bandeau_Titre_Publications-1-768x65.jpg",768,65,true],"large":["https:\/\/www.icta.fr\/wp-content\/uploads\/Bandeau_Titre_Publications-1-1024x86.jpg",1024,86,true],"1536x1536":["https:\/\/www.icta.fr\/wp-content\/uploads\/Bandeau_Titre_Publications-1-1536x130.jpg",1536,130,true],"2048x2048":["https:\/\/www.icta.fr\/wp-content\/uploads\/Bandeau_Titre_Publications-1.jpg",1920,162,false],"post-thumbnail":["https:\/\/www.icta.fr\/wp-content\/uploads\/Bandeau_Titre_Publications-1-1568x132.jpg",1568,132,true],"wpm_taille_1":["https:\/\/www.icta.fr\/wp-content\/uploads\/Bandeau_Titre_Publications-1-364x162.jpg",364,162,true],"wpm_taille_slider":["https:\/\/www.icta.fr\/wp-content\/uploads\/Bandeau_Titre_Publications-1-240x145.jpg",240,145,true],"gform-image-choice-sm":["https:\/\/www.icta.fr\/wp-content\/uploads\/Bandeau_Titre_Publications-1.jpg",300,25,false],"gform-image-choice-md":["https:\/\/www.icta.fr\/wp-content\/uploads\/Bandeau_Titre_Publications-1.jpg",400,34,false],"gform-image-choice-lg":["https:\/\/www.icta.fr\/wp-content\/uploads\/Bandeau_Titre_Publications-1.jpg",600,51,false]},"uagb_author_info":{"display_name":"ictvsi6372","author_link":"https:\/\/www.icta.fr\/fr\/author\/jhvision-icta\/"},"uagb_comment_info":0,"uagb_excerpt":null,"_links":{"self":[{"href":"https:\/\/www.icta.fr\/fr\/wp-json\/wp\/v2\/pages\/669","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.icta.fr\/fr\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.icta.fr\/fr\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.icta.fr\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.icta.fr\/fr\/wp-json\/wp\/v2\/comments?post=669"}],"version-history":[{"count":39,"href":"https:\/\/www.icta.fr\/fr\/wp-json\/wp\/v2\/pages\/669\/revisions"}],"predecessor-version":[{"id":10036,"href":"https:\/\/www.icta.fr\/fr\/wp-json\/wp\/v2\/pages\/669\/revisions\/10036"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.icta.fr\/fr\/wp-json\/wp\/v2\/media\/1378"}],"wp:attachment":[{"href":"https:\/\/www.icta.fr\/fr\/wp-json\/wp\/v2\/media?parent=669"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}